Industry News
Australian innovation gets a head start with Baxter Commercialisation
Baxter Innovation Hub has launched its new commercialisation service, Baxter Commercialisation, comprising an experienced team of industry specialists dedicated to assisting Australian inventors and entrepreneurs in expanding their business and selling their ideas to the world. [ + ]
Mesoblast up following patents in US and China
Mesoblast (ASX:MSB) has made gains on the ASX following an announcement it has secured further patents covering its technology in the US and China. [ + ]
New insight into the catch-22 of obesity and dieting
Australian researchers have unravelled a longstanding mystery of obesity: why is it sometimes counterproductive for obese people to diet? [ + ]
Australia’s first ever snapshot of science engagement
The first national audit of its kind ever to be held in Australia recorded information about 411 different activities that aim to engage ordinary people with science. [ + ]
Allied finds CardioCel better at seeding stem cells
Tests of tissue engineered by Allied Healthcare’s (ASX:AHZ) ADAPT technology support its ability to be used for a “truly regenerative treatment”, according to its CEO. [ + ]
Cynata’s stem cells show promise in treating critical limb ischemia
An animal trial has shown Cynata’s mesenchymoangioblasts (MCA) cells can help improve blood flow in mice with induced critical limb ischemia. [ + ]
Metabolic eyes human trials for experimental osteoarthritis treatment
A positive result from an animal trial of Calzada (ASX:CZD) subsidiary Metabolic Pharmaceuticals’ osteoarthritis treatment could lead to phase II human trials beginning soon. [ + ]
Anti-ageing protein linked to pancreatic cancer
Sirtuin, which is known for its link to ageing, has been associated with pancreatic cancer, raising the prospect of new treatments. [ + ]
Quantum microscope for living biology
A team of Australian scientists has developed a powerful microscope using the laws of quantum mechanics to probe the inner workings of living cells. [ + ]
Academy welcomes new Science Minister
The Australian Academy of Science today welcomed the appointment of Chris Bowen as the new Minister for Science and Research. [ + ]
Discovery in synthetic biology takes us a step closer to new industrial revolution
Scientists report that they have developed a method that cuts down the time it takes to make new ‘parts’ for microscopic biological factories from two days to only six hours. [ + ]
New leader for Australia’s astronomy and space science research
CSIRO’s astronomy, spacecraft tracking and space science activities will be headed up by a new leader, with the announcement that Dr Lewis Ball has been appointed as the incoming chief for CSIRO’s Astronomy and Space Science (CASS) division. [ + ]
PolyNovo to file with FDA to seek NovoSorb in US
Calzada (ASX:CZD) subsidiary PolyNovo will seek marketing approval in the US for NovoSorb, its dressing for hard-to-heal pressure sores. [ + ]
BioDiem expanding indications for BDM-I
BioDiem (ASX:BDM) is extending a research agreement with US-based NIAID to cover the evaluation of antimicrobial BDM-I in tuberculosis and serious fungal infections. [ + ]
Alchemia progresses with colorectal cancer trial
Alchemia (ASX:ACL) has enrolled the 390th patient for its phase III trial of HA-Irinotecan in metastatic colorectal cancer and expects to reach the primary endpoint in early 2014. [ + ]
